Efficacy and Safety of Polyherbal formulation as an add-on to the standard of care in mild to moderate COVID-19: A randomized, double-blind, placebo-controlled trial

Suresh B. Patankar, Hrishikesh Rangnekar, Kalpana Joshi, Kishor Suryawanshi, Pravin Soni, Anupama Gorde, Tejas Shah, Sagar Patankar, Diwakar Jha, Rajesh Raje
doi: https://doi.org/10.1101/2021.05.14.21256900

Article usage

Article usage: May 2021 to August 2025

AbstractFullPdf
May 20214822672
Jun 20211071829
Jul 2021911215
Aug 20211382016
Sep 2021521523
Oct 2021491436
Nov 2021421718
Dec 2021471819
Jan 2022501812
Feb 20223378
Mar 20223046
Apr 202230216
May 202230111
Jun 202233010
Jul 20222303
Aug 202238711
Sep 202231321
Oct 202232210
Nov 20222039
Dec 202217511
Jan 202322614
Feb 20231668
Mar 20233265
Apr 202319420
May 202314213
Jun 20231179
Jul 20238165
Aug 202316137
Sep 20231565
Oct 20231119
Nov 2023331619
Dec 20231647
Jan 20241739
Feb 20242419
Mar 2024151710
Apr 20247114
May 202417419
Jun 202416321
Jul 202410519
Aug 202411211
Sep 202415713
Oct 202418310
Nov 202420112
Dec 202412112
Jan 202511911
Feb 2025112612
Mar 2025334021
Apr 2025221615
May 202521139
Jun 2025271615
Jul 202515910
Aug 2025469
Back to top
Posted May 14, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Efficacy and Safety of Polyherbal formulation as an add-on to the standard of care in mild to moderate COVID-19: A randomized, double-blind, placebo-controlled trial
Suresh B. Patankar, Hrishikesh Rangnekar, Kalpana Joshi, Kishor Suryawanshi, Pravin Soni, Anupama Gorde, Tejas Shah, Sagar Patankar, Diwakar Jha, Rajesh Raje
medRxiv 2021.05.14.21256900; doi: https://doi.org/10.1101/2021.05.14.21256900
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area